SUN Zhencan, ZHOU Jukun, XU Yunpeng, WANG Jun, ZHENG Ya, WANG Yuping, JI Rui. Mechanism of Epithelial-mesenchymal Transition Leading to Gastric Cancer Induced by Helicobacter pylori[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 160-165. DOI: 10.12290/xhyxzz.2023-0341
Citation: SUN Zhencan, ZHOU Jukun, XU Yunpeng, WANG Jun, ZHENG Ya, WANG Yuping, JI Rui. Mechanism of Epithelial-mesenchymal Transition Leading to Gastric Cancer Induced by Helicobacter pylori[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 160-165. DOI: 10.12290/xhyxzz.2023-0341

Mechanism of Epithelial-mesenchymal Transition Leading to Gastric Cancer Induced by Helicobacter pylori

Funds: 

Lanzhou Talent Innovation and Entrepreneurship Project 2019-RC-33

Directional Exploration Project of Medical Department of Lanzhou University lzuyxcx-2022-184

More Information
  • Corresponding author:

    JI Rui, E-mail: jir@lzu.edu.cn

  • Received Date: July 22, 2023
  • Accepted Date: September 07, 2023
  • Issue Publish Date: January 29, 2024
  • Helicobacter pylori (Hp) is a unipolar, microaerobic, multiflagellar, spiral-shaped Gram-negative bacterium that survives and colonizes human gastric mucosa. As a classⅠcarcinogen associated with gastric cancer, long-term stimulation of gastric mucosa by Hp can cause atrophic gastritis, peptic ulcer, gastric cancer and gastric mucosa-associated lymphoid tissue lymphoma. It has been reported that Hp can cause epithelial-mesenchymal transition (EMT) in gastric epithelial cells, thereby inducing gastric cancer. We review the mechanism of Hp-induced EMT in gastric epithelial cells, in order to provide new insights for early diagnosis and targeted therapy of gastric cancer.
  • [1]
    刘宗超, 李哲轩, 张阳, 等. 2020全球癌症统计报告解读[J]. 肿瘤综合治疗电子杂志, 2021, 7(2): 1-13.

    Liu Z C, Li Z X, Zhang Y, et al. Interpretation on the report of Global Cancer Statistics 2020[J]. J Multidiscip Cancer Manag (Electron Version), 2021, 7(2): 1-13.
    [2]
    Li M M, Sun Y Y, Yang J, et al. Time trends and other sources of variation in Helicobacter pylori infection in mainland China: a systematic review and meta-analysis[J]. Helicobacter, 2020, 25(5): e12729. DOI: 10.1111/hel.12729
    [3]
    Čipak Gašparović A, Milković L, Dandachi N, et al. Chronic oxidative stress promotes molecular changes associated with epithelial mesenchymal transition, NRF2, and breast cancer stem cell phenotype[J]. Antioxidants (Basel), 2019, 8(12): 633. DOI: 10.3390/antiox8120633
    [4]
    Buhrmann C, Yazdi M, Popper B, et al. Induction of the epithelial-to-mesenchymal transition of human colorectal cancer by human TNF-β (lymphotoxin) and its reversal by resveratrol[J]. Nutrients, 2019, 11(3): 704. DOI: 10.3390/nu11030704
    [5]
    Sun Z W, Cai S, Liu C, et al. Increased expression of gremlin1 promotes proliferation and epithelial mesenchymal transition in gastric cancer cells and correlates with poor prognosis of patients with gastric cancer[J]. Cancer Genomics Proteomics, 2020, 17(1): 49-60. DOI: 10.21873/cgp.20167
    [6]
    Sannino G, Marchetto A, Kirchner T, et al. Epithelial-to-mesenchymal and mesenchymal-to-epithelial transition in mesen-chymal tumors: a paradox in sarcomas?[J]. Cancer Res, 2017, 77(17): 4556-4561. DOI: 10.1158/0008-5472.CAN-17-0032
    [7]
    Jung H J, Hong S J, Kim S H. Immunohistochemical expression of epithelial-mesenchymal transition markers in early gastric cancer: cancer tissue versus noncancer tissue[J]. Clin Endosc, 2019, 52(5): 464-471. DOI: 10.5946/ce.2018.181
    [8]
    Lee D G, Kim H S, Lee Y S, et al. Helicobacter pylori CagA promotes Snail-mediated epithelial-mesenchymal transition by reducing GSK-3 activity[J]. Nat Commun, 2014, 5(1): 4423. DOI: 10.1038/ncomms5423
    [9]
    Lee S D, Jeong H, Hwang B R, et al. Helicobacter pylori promotes epithelial-to-mesenchymal transition by downregulat-ing CK2β in gastric cancer cells[J]. Biochim Biophys Acta Mol Basis Dis, 2023, 1869(1): 166588. DOI: 10.1016/j.bbadis.2022.166588
    [10]
    Yu H, Zeng J P, Liang X M, et al. Helicobacter pylori promotes epithelial-mesenchymal transition in gastric cancer by downregulating programmed cell death protein 4 (PDCD4)[J]. PLoS One, 2014, 9(8): e105306. DOI: 10.1371/journal.pone.0105306
    [11]
    Choi S I, Yoon C, Park M R, et al. CDX1 expression induced by CagA-expressing Helicobacter pylori promotes gastric tumorigenesis[J]. Mol Cancer Res, 2019, 17(11): 2169-2183. DOI: 10.1158/1541-7786.MCR-19-0181
    [12]
    张珊珊, 苗丰, 刘露, 等. 幽门螺杆菌毒力因子CagA对人正常胃上皮HFE145细胞CDX1表达及上皮间质转化的影响[J]. 中国医药导报, 2021, 18(25): 35-39.

    Zhang S S, Miao F, Liu L, et al. Effect of CagA on CDX1 expression and epithelial mesenchymal transition in human normal gastric epithelial HFE145 cells[J]. Chin Med Herald, 2021, 18(25): 35-39.
    [13]
    Chen Y A, Lu C Y, Cheng T Y, et al. WW domain-containing proteins YAP and TAZ in the hippo pathway as key regula-tors in stemness maintenance, tissue homeostasis, and tumorigenesis[J]. Front Oncol, 2019, 9: 60. DOI: 10.3389/fonc.2019.00060
    [14]
    Li N S, Feng Y, Hu Y, et al. Helicobacter pylori CagA promotes epithelial mesenchymal transition in gastric carcino-genesis via triggering oncogenic YAP pathway[J]. J Exp Clin Cancer Res, 2018, 37(1): 280. DOI: 10.1186/s13046-018-0962-5
    [15]
    Li N S, Xu X B, Yang H, et al. Activation of aquaporin 5 by carcinogenic Helicobacter pylori infection promotes epithelial-mesenchymal transition via the MEK/ERK pathway[J]. Helicobacter, 2021, 26(5): e12842. DOI: 10.1111/hel.12842
    [16]
    Bessède E, Staedel C, Acu a Amador L A, et al. Helicobacter pylori generates cells with cancer stem cell properties via epithelial-mesenchymal transition-like changes[J]. Oncogene, 2014, 33(32): 4123-4131. DOI: 10.1038/onc.2013.380
    [17]
    Lin L, Wei H L, Yi J, et al. Chronic CagA-positive Helicobacter pylori infection with MNNG stimulation synergistically induces mesenchymal and cancer stem cell-like properties in gastric mucosal epithelial cells[J]. J Cell Biochem, 2019, 120(10): 17635-17649. DOI: 10.1002/jcb.29031
    [18]
    Watanabe T, Takahashi A, Suzuki K, et al. Epithelial-mesenchymal transition in human gastric cancer cell lines induced by TNF-α-inducing protein of Helicobacter pylori[J]. Int J Cancer, 2014, 134(10): 2373-2382. DOI: 10.1002/ijc.28582
    [19]
    Chen G D, Tang N, Wang C, et al. TNF-α-inducing protein of Helicobacter pylori induces epithelial-mesenchymal transi-tion (EMT) in gastric cancer cells through activation of IL-6/STAT3 signaling pathway[J]. Biochem Biophys Res Commun, 2017, 484(2): 311-317. DOI: 10.1016/j.bbrc.2017.01.110
    [20]
    Guo K Y, Duan J, Lu J W, et al. Tumor necrosis factor-α-inducing protein of Helicobacter pylori promotes epithelial-mesenchymal transition and cancer stem-like cells properties via activation of Wnt/β-catenin signaling pathway in gastric cancer cells[J]. Pathog Dis, 2022, 80(1): ftac025. DOI: 10.1093/femspd/ftac025
    [21]
    曾莎莎, 肖玲巧, 唐瑶, 等. 幽门螺杆菌Tipα通过Wnt/β-catenin通路诱导胃癌细胞EMT[J]. 中南医学科学杂志, 2020, 48(6): 618-623.

    Zeng S S, Xiao L Q, Tang Y, et al. Tipα protein of Helicobacter pylori induces EMT in gastric cancer cell through Wnt/β-catenin signaling pathway[J]. Med Sci J Cent South China, 2020, 48(6): 618-623.
    [22]
    Li W, Zhang X, Wu F L, et al. Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer[J]. Cell Death Dis, 2019, 10(12): 918. DOI: 10.1038/s41419-019-2131-y
    [23]
    Zhang Q, Ding J, Liu J J, et al. Helicobacter pylori-infected MSCs acquire a pro-inflammatory phenotype and induce hu-man gastric cancer migration by promoting EMT in gastric cancer cells[J]. Oncol Lett, 2016, 11(1): 449-457. DOI: 10.3892/ol.2015.3897
    [24]
    Zhang Q, Wang M, Huang F, et al. H. pylori infection-induced MSC differentiation into CAFs promotes epithelial-mesenchymal transition in gastric epithelial cells[J]. Int J Mol Med, 2013, 32(6): 1465-1473. DOI: 10.3892/ijmm.2013.1532
    [25]
    Zhang Q, Chai S, Wang W, et al. Macrophages activate mesenchymal stem cells to acquire cancer-associated fibroblast-like features resulting in gastric epithelial cell lesions and malignant transformation in vitro[J]. Oncol Lett, 2019, 17(1): 747-756.
    [26]
    Krzysiek-Maczka G, Targosz A, Szczyrk U, et al. Role of Helicobacter pylori infection in cancer-associated fibro-blast-induced epithelial-mesenchymal transition in vitro[J]. Helicobacter, 2018, 23(6): e12538. DOI: 10.1111/hel.12538
    [27]
    Krzysiek-Maczka G, Targosz A, Szczyrk U, et al. Involvement of epithelial-mesenchymal transition-inducing transcription factors in the mechanism of Helicobacter pylori-induced fibroblasts activation[J]. J Physiol Pharmacol, 2019, 70(5): 727-736.
    [28]
    Zhu Y L, Jiang Q L, Lou X J, et al. MicroRNAs up-regulated by CagA of Helicobacter pylori induce intestinal metaplasia of gastric epithelial cells[J]. PLoS One, 2012, 7(4): e35147. DOI: 10.1371/journal.pone.0035147
    [29]
    Sun F Y, Ni Y, Zhu H, et al. microRNA-29a-3p, up-regulated in human gastric cells and tissues with H. pylori infection, promotes the migration of GES-1 cells via A20-mediated EMT pathway[J]. Cell Physiol Biochem, 2018, 51(3): 1250-1263. DOI: 10.1159/000495502
    [30]
    Shi Y Y, Yang Z W, Zhang T, et al. SIRT1-targeted miR-543 autophagy inhibition and epithelial-mesenchymal transition promotion in Helicobacter pylori CagA-associated gastric cancer[J]. Cell Death Dis, 2019, 10(9): 625. DOI: 10.1038/s41419-019-1859-8
    [31]
    Ou Y, Ren H F, Zhao R R, et al. Helicobacter pylori CagA promotes the malignant transformation of gastric mucosal epithelial cells through the dysregulation of the miR-155/KLF4 signaling pathway[J]. Mol Carcinog, 2019, 58(8): 1427-1437. DOI: 10.1002/mc.23025
    [32]
    Qu M, Li L, Zheng W C. Reduced miR-490-3p expression is associated with poor prognosis of Helicobacter pylori induced gastric cancer[J]. Eur Rev Med Pharmacol Sci, 2017, 21(15): 3384-3388.
    [33]
    Shen J, Xiao Z G, Wu W K K, et al. Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pylori-induced gastric carcinogenesis[J]. Cancer Res, 2015, 75(4): 754-765. DOI: 10.1158/0008-5472.CAN-14-1301
    [34]
    Huang L, Wang Z Y, Pan D D. Penicillin-binding protein 1A mutation-positive Helicobacter pylori promotes epithelial-mesenchymal transition in gastric cancer via the suppression of microRNA-134[J]. Int J Oncol, 2019, 54(3): 916-928.
    [35]
    Che Y, Geng B, Xu Y, et al. Helicobacter pylori-induced exosomal MET educates tumour-associated macrophages to promote gastric cancer progression[J]. J Cell Mol Med, 2018, 22(11): 5708-5719. DOI: 10.1111/jcmm.13847
    [36]
    Ouyang Y B, Liu G M I, Xu W T, et al. Helicobacter pylori induces epithelial-mesenchymal transition in gastric carcino-genesis via the AKT/GSK3β signaling pathway[J]. Oncol Lett, 2021, 21(2): 165. DOI: 10.3892/ol.2021.12426
    [37]
    Marques M S, Melo J, Cavadas B, et al. Afadin downregulation by Helicobacter pylori induces epithelial to mesenchymal transition in gastric cells[J]. Front Microbiol, 2018, 9: 2712. DOI: 10.3389/fmicb.2018.02712
    [38]
    Zhou S F, Chen H, Yuan P H, et al. Helicobacter pylori infection promotes epithelial-to-mesenchymal transition of gastric cells by upregulating LAPTM4B[J]. Biochem Biophys Res Commun, 2019, 514(3): 893-900. DOI: 10.1016/j.bbrc.2019.05.036
    [39]
    Bacon S, Seeneevassen L, Fratacci A, et al. Nrf2 downregulation contributes to epithelial-to-mesenchymal transition in Helicobacter pylori-infected cells[J]. Cancers (Basel), 2022, 14(17): 4316. DOI: 10.3390/cancers14174316
    [40]
    Kim H S, Lim J W, Kim H. Korean red ginseng extract inhibits IL-8 expression via Nrf2 activation in Helicobacter pylori-infected gastric epithelial cells[J]. Nutrients, 2022, 14(5): 1044. DOI: 10.3390/nu14051044
    [41]
    Zhang Y F, Sun J, Dong Y, et al. Vicenin-2 inhibits the Helicobacterium pylori infection associated gastric carcino-genic events through modulation of PI3K/AKT and Nrf2 signaling in GES-1 cells[J]. J Biochem Mol Toxicol, 2021, 35(3): e22680. DOI: 10.1002/jbt.22680
  • Cited by

    Periodical cited type(2)

    1. 孙树申,宋蕊,华德芳,李雪,吕洪敏. 血清PGⅠ、PGⅡ、PGR结合G-17及Hp检测用于早期胃癌和癌前病变的鉴别价值. 中国老年学杂志. 2024(18): 4377-4380 .
    2. 覃奉道,吴付力,韦振媚,班露丝,黄荣,郭先文. 四联疗法根除幽门螺杆菌10 d疗程和14 d疗程的对比研究. 吉林医学. 2024(11): 2649-2651 .

    Other cited types(3)

Catalog

    Article Metrics

    Article views (185) PDF downloads (22) Cited by(5)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close